Cosmegen
Links shared publicly online about this topic
Bedford Laboratories launches Dactinomycin for Injection
news-medical.net — “Bedford Laboratories", a division of Ben Venue Laboratories, Inc., is pleased to announce the addition of Dactinomycin for Injection USP 500 mcg (0.5 mg) to its comprehensive line of generic oncology products. Dactinomycin was approved earlier this year by the U.S. Food and Drug Administration (FDA) and is AP rated and equivalent to Cosmegen® by Lundbeck Inc. Each single dose vial contains 0.5 mg (500mcg) of dactinomycin and 20 mg of mannitol and is individually boxed.” View full resource at news-medical.net
Most Recently Shared on July 12, 2010 at 5:46 pm By:
News-Medical.Net Health News and Oncology
Oncology News: Bedford Laboratories launches Dactinomycin for Injection: Bedford Laboratoriesâ„¢, a division of Ben ... http://bit.ly/ditnGi
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
News-Medical.Net
Stay up to date with the latest Oncology news and research via News-Medical.Net
Advertisement
